Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
Charles Schwab
SCHW
|
+$1.44B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.06B |
| 3 |
GE HealthCare
GEHC
|
+$519M |
| 4 |
Danaher
DHR
|
+$420M |
| 5 |
American Electric Power
AEP
|
+$387M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$941M |
| 2 |
Boeing
BA
|
+$880M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$819M |
| 4 |
Bank of America
BAC
|
+$705M |
| 5 |
Coca-Cola
KO
|
+$684M |
Sector Composition
| 1 | Healthcare | 16.71% |
| 2 | Technology | 14.92% |
| 3 | Financials | 12.44% |
| 4 | Consumer Discretionary | 11.46% |
| 5 | Industrials | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GGT
5151
Gabelli Multimedia Trust
GGT
$152M
| $90.8K | ﹤0.01% |
19,614
+2,434
| +14% | +$11.3K |
|
5152
Lunai Bioworks Inc. Common Stock
RENB
$42.3M
| $90.2K | ﹤0.01% |
+166,083
| New | +$90.2K |
|
5153
Limbach Holdings
LMB
$1.15B
| $89.7K | ﹤0.01% |
1,205
-20,909
| -95% | -$1.56M |
|
5154
WisdomTree Cloud Computing Fund
WCLD
$333M
| $89K | ﹤0.01% |
2,744
-33,689
| -92% | -$1.09M |
|
5155
Riley Exploration Permian
REPX
$618M
| $88.9K | ﹤0.01% |
3,046
-6,432
| -68% | -$188K |
|
5156
Capital Group Dividend Value ETF
CGDV
$22B
| $88.7K | ﹤0.01% |
2,488
-30,448
| -92% | -$1.09M |
|
5157
Nautilus Biotechnolgy
NAUT
$94.8M
| $88.6K | ﹤0.01% |
102,928
-117,292
| -53% | -$101K |
|
5158
RAPT Therapeutics
RAPT
$292M
| $88.5K | ﹤0.01% |
9,072
+9,059
| +69,685% | +$88.4K |
|
5159
TIM SA
TIMB
$10.4B
| $88.4K | ﹤0.01% |
+5,647
| New | +$88.4K |
|
5160
LiveWire
LVWR
$1.08B
| $88K | ﹤0.01% |
44,018
+23,423
| +114% | +$46.8K |
|
|
PHK
5161
PIMCO High Income Fund
PHK
$853M
| $87.8K | ﹤0.01% |
17,951
-4,220
| -19% | -$20.6K |
|
5162
Orchestra BioMed
OBIO
$137M
| $87.7K | ﹤0.01% |
20,480
+8,201
| +67% | +$35.1K |
|
|
GRCE
5163
Grace Therapeutics, Inc. Common Stock
GRCE
$42.7M
| $87.6K | ﹤0.01% |
38,403
+14,739
| +62% | +$33.6K |
|
5164
SuRo Capital
SSSS
$218M
| $87.5K | ﹤0.01% |
17,613
-63,395
| -78% | -$315K |
|
5165
Loop Industries
LOOP
$88.3M
| $87.3K | ﹤0.01% |
+75,936
| New | +$87.3K |
|
|
ATLN
5166
Atlantic International Corp. Common Stock
ATLN
$208M
| $87.1K | ﹤0.01% |
+21,613
| New | +$87.1K |
|
|
NURO
5167
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
| $87.1K | ﹤0.01% |
+19,610
| New | +$87.1K |
|
5168
Phunware
PHUN
$55.9M
| $86.2K | ﹤0.01% |
+29,228
| New | +$86.2K |
|
|
ADXN
5169
Addex Therapeutics
ADXN
$10M
| $86.2K | ﹤0.01% |
11,741
-338
| -3% | -$2.48K |
|
5170
Estrella Immunopharma
ESLA
$41.5M
| $84.9K | ﹤0.01% |
+91,599
| New | +$84.9K |
|
|
SIFY
5171
Sify Technologies
SIFY
$880M
| $84.7K | ﹤0.01% |
19,788
-10,553
| -35% | -$45.2K |
|
|
YSXT
5172
YSX Tech. Co., Ltd Class A Ordinary Shares
YSXT
$62.3M
| $83.9K | ﹤0.01% |
29,660
+10,611
| +56% | +$30K |
|
5173
Helios Technologies
HLIO
$1.8B
| $83.2K | ﹤0.01% |
2,594
-6,444
| -71% | -$207K |
|
5174
VOC Energy
VOC
$49.1M
| $82.8K | ﹤0.01% |
26,291
+26,077
| +12,186% | +$82.1K |
|
5175
AudioEye
AEYE
$166M
| $82.6K | ﹤0.01% |
7,440
-19,544
| -72% | -$217K |
|